EUVIMEDEUVIMED entdecken
Multizentrische Studie

Potential Predictors of Biological Therapy Intensification in Moderate‐To‐Severe Hidradenitis Suppurativa: A Multicentre Study

Francisco Javier Melgosa Ramos iD, Ramón García Ruiz, Antonio Martorell

Australasian Journal of Dermatology · 2025-03 · 66 (2)

DOI: 10.1111/ajd.14412 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 07.01.2025. Verfasst von Francisco Javier Melgosa Ramos und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Doctor Peset, Valencia, Spain. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Adalimumab, Biosimilar Pharmaceuticals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moderate‐to‐severe hidradenitis suppurativa (HS) is a debilitating disease that often requires biological therapy. Despite the effectiveness of approved doses, some patients experience partial or loss of response over time, leading to the need for dose intensification. This retrospective multicentre study aimed to identify predictors of biological therapy intensification in HS patients. The results showed that prior use of biological treatments and biosimilar adalimumab were significant predictors of intensification, suggesting closer monitoring may be needed for certain patient profiles to optimise treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdalimumabBiosimilar PharmaceuticalsHumansRetrospective StudiesMaleFemaleAdultMiddle AgedSeverity of Illness Index

Stichwörter der Autor:innen

disease modificationhidradenitis suppurativaintensificationwindow of opportunity

Substanzen

AdalimumabBiosimilar Pharmaceuticals

Autor:innen und Institutionen

  • University Hospital Doctor Peset, Valencia, Spain.
  • Department of Dermatology, Hospital Lluís Alcanyís, Valencia, Spain.
  • Department of Dermatology, Hospital of Manises, Valencia, Spain.

ORCID-Profile: Francisco Javier Melgosa Ramos

Zitieren

APA

Melgosa Ramos, F. J., García Ruiz, R., & Martorell, A. (2025). Potential Predictors of Biological Therapy Intensification in Moderate‐To‐Severe Hidradenitis Suppurativa: A Multicentre Study. Australasian Journal of Dermatology, 66(2). https://doi.org/10.1111/ajd.14412

Vancouver

Melgosa Ramos FJ, García Ruiz R, Martorell A. Potential Predictors of Biological Therapy Intensification in Moderate‐To‐Severe Hidradenitis Suppurativa: A Multicentre Study. Australasian Journal of Dermatology. 2025;66(2). doi:10.1111/ajd.14412

BibTeX
@article{MelgosaRamos2025,
  author = {Melgosa Ramos, Francisco Javier and García Ruiz, Ramón and Martorell, Antonio},
  title = {Potential Predictors of Biological Therapy Intensification in Moderate‐To‐Severe Hidradenitis Suppurativa: A Multicentre Study},
  journal = {Australasian Journal of Dermatology},
  year = {2025},
  volume = {66},
  number = {2},
  doi = {10.1111/ajd.14412}
}
Kostenlos starten →